Papers published by consortium members after 2015

1: Akhade VS, Pal D, Kanduri C. Long Noncoding RNA: Genome Organization and Mechanism of Action. Adv Exp Med Biol. 2017;1008:47-74. doi:
10.1007/978-981-10-5203-3_2. PubMed PMID: 28815536.

2: Dyberg C, Fransson S, Andonova T, Sveinbjörnsson B, Lännerholm-Palm J, Olsen TK, Forsberg D, Herlenius E, Martinsson T, Brodin B, Kogner P, Johnsen JI, Wickström M. Rho-associated kinase is a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6603-E6612. doi:
10.1073/pnas.1706011114. Epub 2017 Jul 24. PubMed PMID: 28739902; PubMed Central
PMCID: PMC5559038.

3: Morud J, Ashouri A, Larsson E, Ericson M, Söderpalm B. Transcriptional
profiling of the rat nucleus accumbens after modest or high alcohol exposure.
PLoS One. 2017 Jul 17;12(7):e0181084. doi: 10.1371/journal.pone.0181084.
eCollection 2017. PubMed PMID: 28715440; PubMed Central PMCID: PMC5513432.

4: Westerlund I, Shi Y, Toskas K, Fell SM, Li S, Surova O, Södersten E, Kogner P,
Nyman U, Schlisio S, Holmberg J. Combined epigenetic and differentiation-based
treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor
suppression. Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6137-E6146. doi:
10.1073/pnas.1700655114. Epub 2017 Jul 10. PubMed PMID: 28696319; PubMed Central
PMCID: PMC5544284.

5: Fell SM, Li S, Wallis K, Kock A, Surova O, Rraklli V, Höfig CS, Li W, Mittag
J, Henriksson MA, Kenchappa RS, Holmberg J, Kogner P, Schlisio S. Neuroblast
differentiation during development and in neuroblastoma requires KIF1Bβ-mediated
transport of TRKA. Genes Dev. 2017 May 15;31(10):1036-1053. doi:
10.1101/gad.297077.117. PubMed PMID: 28637693; PubMed Central PMCID: PMC5495120.

6: Moreno L, Caron H, Geoerger B, Eggert A, Schleiermacher G, Brock P,
Valteau-Couanet D, Chesler L, Schulte JH, De Preter K, Molenaar J, Schramm A,
Eilers M, Van Maerken T, Johnsen JI, Garrett M, George SL, Tweddle DA, Kogner P,
Berthold F, Koster J, Barone G, Tucker ER, Marshall L, Herold R, Sterba J, Norga
K, Vassal G, Pearson AD. Accelerating drug development for neuroblastoma – New
Drug Development Strategy: an Innovative Therapies for Children with Cancer,
European Network for Cancer Research in Children and Adolescents and
International Society of Paediatric Oncology Europe Neuroblastoma project. Expert
Opin Drug Discov. 2017 Aug;12(8):801-811. doi: 10.1080/17460441.2017.1340269.
Epub 2017 Jun 26. Review. PubMed PMID: 28604107.

7: Fredriksson NJ, Elliott K, Filges S, Van den Eynden J, Ståhlberg A, Larsson E.
Recurrent promoter mutations in melanoma are defined by an extended
context-specific mutational signature. PLoS Genet. 2017 May 10;13(5):e1006773.
doi: 10.1371/journal.pgen.1006773. eCollection 2017 May. PubMed PMID: 28489852;
PubMed Central PMCID: PMC5443578.

8: Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M,
Lannering B, Enlund F, Martinsson T, Åman P, Abel F. A new GTF2I-BRAF fusion
mediating MAPK pathway activation in pilocytic astrocytoma. PLoS One. 2017 Apr
27;12(4):e0175638. doi: 10.1371/journal.pone.0175638. eCollection 2017. PubMed
PMID: 28448514; PubMed Central PMCID: PMC5407815.

9: Stenman J, Herold N, Svensson PJ, Kogner P. Improved Local Control by
Extensive Surgery in High-Risk Neuroblastoma May Be Dependent on Adjuvant
Radiotherapy. J Clin Oncol. 2017 Jun 10;35(17):1965-1966. doi:
10.1200/JCO.2016.72.1175. Epub 2017 Apr 19. PubMed PMID: 28422555.

10: Sandén E, Dyberg C, Krona C, Gallo-Oller G, Olsen TK, Enríquez Pérez J,
Wickström M, Estekizadeh A, Kool M, Visse E, Ekström TJ, Siesjö P, Johnsen JI,
Darabi A. Establishment and characterization of an orthotopic patient-derived
Group 3 medulloblastoma model for preclinical drug evaluation. Sci Rep. 2017 Apr
18;7:46366. doi: 10.1038/srep46366. PubMed PMID: 28417956; PubMed Central PMCID:
PMC5394470.

11: Zhou K, Xie C, Wickström M, Dolga AM, Zhang Y, Li T, Xu Y, Culmsee C, Kogner
P, Zhu C, Blomgren K. Lithium protects hippocampal progenitors, cognitive
performance and hypothalamus-pituitary function after irradiation to the juvenile
rat brain. Oncotarget. 2017 May 23;8(21):34111-34127. doi:
10.18632/oncotarget.16292. PubMed PMID: 28415806; PubMed Central PMCID:
PMC5470955.

12: Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I,
Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de
Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF,
Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D;
SIOP Europe Neuroblastoma Group (SIOPEN). Busulfan and melphalan versus
carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk
neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm,
open-label, phase 3 trial. Lancet Oncol. 2017 Apr;18(4):500-514. doi:
10.1016/S1470-2045(17)30070-0. Epub 2017 Mar 2. PubMed PMID: 28259608.

13: Eissler N, Mao Y, Brodin D, Reuterswärd P, Andersson Svahn H, Johnsen JI,
Kiessling R, Kogner P. Regulation of myeloid cells by activated T cells
determines the efficacy of PD-1 blockade. Oncoimmunology. 2016 Sep
9;5(12):e1232222. doi: 10.1080/2162402X.2016.1232222. eCollection 2016. PubMed
PMID: 28123870; PubMed Central PMCID: PMC5214950.

14: Vizlin-Hodzic D, Zhai Q, Illes S, Södersten K, Truvé K, Parris TZ, Sobhan PK,
Salmela S, Kosalai ST, Kanduri C, Strandberg J, Seth H, Bontell TO, Hanse E,
Ågren H, Funa K. Early onset of inflammation during ontogeny of bipolar disorder:
the NLRP2 inflammasome gene distinctly differentiates between patients and
healthy controls in the transition between iPS cell and neural stem cell stages.
Transl Psychiatry. 2017 Jan 24;7(1):e1010. doi: 10.1038/tp.2016.284. PubMed PMID:
28117838; PubMed Central PMCID: PMC5545741.

15: Herold N, Rudd SG, Ljungblad L, Sanjiv K, Myrberg IH, Paulin CB, Heshmati Y,
Hagenkort A, Kutzner J, Page BD, Calderón-Montaño JM, Loseva O, Jemth AS, Bulli
L, Axelsson H, Tesi B, Valerie NC, Höglund A, Bladh J, Wiita E, Sundin M, Uhlin
M, Rassidakis G, Heyman M, Tamm KP, Warpman-Berglund U, Walfridsson J, Lehmann S,
Grandér D, Lundbäck T, Kogner P, Henter JI, Helleday T, Schaller T. Targeting
SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological
malignancies. Nat Med. 2017 Feb;23(2):256-263. doi: 10.1038/nm.4265. Epub 2017
Jan 9. PubMed PMID: 28067901.

16: Guan J, Wolfstetter G, Siaw J, Chand D, Hugosson F, Palmer RH, Hallberg B.
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic
thyroid cancer patients are not ligand-independent. Oncotarget. 2017 Feb
14;8(7):11566-11578. doi: 10.18632/oncotarget.14141. PubMed PMID: 28030793;
PubMed Central PMCID: PMC5355286.

17: Van den Eynden J, Basu S, Larsson E. Somatic Mutation Patterns in Hemizygous
Genomic Regions Unveil Purifying Selection during Tumor Evolution. PLoS Genet.
2016 Dec 27;12(12):e1006506. doi: 10.1371/journal.pgen.1006506. eCollection 2016
Dec. PubMed PMID: 28027311; PubMed Central PMCID: PMC5189942.

18: Alaei-Mahabadi B, Bhadury J, Karlsson JW, Nilsson JA, Larsson E. Global
analysis of somatic structural genomic alterations and their impact on gene
expression in diverse human cancers. Proc Natl Acad Sci U S A. 2016 Nov
29;113(48):13768-13773. Epub 2016 Nov 16. PubMed PMID: 27856756; PubMed Central
PMCID: PMC5137778.

19: Karlsson J, Larsson E. FocalScan: Scanning for altered genes in cancer based
on coordinated DNA and RNA change. Nucleic Acids Res. 2016 Nov 2;44(19):e150.
Epub 2016 Jul 29. PubMed PMID: 27474725; PubMed Central PMCID: PMC5100559.

20: Subhash S, Andersson PO, Kosalai ST, Kanduri C, Kanduri M. Global DNA
methylation profiling reveals new insights into epigenetically deregulated
protein coding and long noncoding RNAs in CLL. Clin Epigenetics. 2016 Oct
12;8:106. eCollection 2016. PubMed PMID: 27777635; PubMed Central PMCID:
PMC5062931.

21: Subhash S, Kanduri C. GeneSCF: a real-time based functional enrichment tool
with support for multiple organisms. BMC Bioinformatics. 2016 Sep 13;17(1):365.
doi: 10.1186/s12859-016-1250-z. PubMed PMID: 27618934; PubMed Central PMCID:
PMC5020511.

22: Hallberg B, Palmer RH. The role of the ALK receptor in cancer biology. Ann
Oncol. 2016 Sep;27 Suppl 3:iii4-iii15. doi: 10.1093/annonc/mdw301. Review. PubMed
PMID: 27573755.

23: Zaman F, Kogner P, Sävendahl L. Venetoclax in cancer therapy and potential
effects on bone. Lancet Oncol. 2016 Aug;17(8):e319-e320. doi:
10.1016/S1470-2045(16)30228-5. PubMed PMID: 27511157.

24: Guan J, Tucker ER, Wan H, Chand D, Danielson LS, Ruuth K, El Wakil A, Witek
B, Jamin Y, Umapathy G, Robinson SP, Johnson TW, Smeal T, Martinsson T, Chesler
L, Palmer RH, Hallberg B. The ALK inhibitor PF-06463922 is effective as a single
agent in neuroblastoma driven by expression of ALK and MYCN. Dis Model Mech. 2016
Sep 1;9(9):941-52. doi: 10.1242/dmm.024448. Epub 2016 Jul 7. PubMed PMID:
27483357; PubMed Central PMCID: PMC5047689.

25: Snapkov I, Öqvist CO, Figenschau Y, Kogner P, Johnsen JI, Sveinbjørnsson B.
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis. BMC
Cancer. 2016 Jul 18;16:490. doi: 10.1186/s12885-016-2545-1. PubMed PMID:
27432059; PubMed Central PMCID: PMC4950242.

26: Ribeiro D, Klarqvist MD, Westermark UK, Oliynyk G, Dzieran J, Kock A,
Savatier Banares C, Hertwig F, Johnsen JI, Fischer M, Kogner P, Lovén J, Arsenian
Henriksson M. Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs
Impacts Neural Differentiation and Survival in Neuroblastoma Patients. Cell Rep.
2016 Jul 26;16(4):979-93. doi: 10.1016/j.celrep.2016.06.052. Epub 2016 Jul 7.
PubMed PMID: 27396325.

27: Johnsen JI, Wickström M, Baryawno N. Wingless/β-catenin signaling as a
modulator of chemoresistance in cancer. Mol Cell Oncol. 2016 Jan
19;3(2):e1131356. doi: 10.1080/23723556.2015.1131356. eCollection 2016 Mar.
PubMed PMID: 27308637; PubMed Central PMCID: PMC4905426.

28: Shah PS, Lui K, Sjörs G, Mirea L, Reichman B, Adams M, Modi N, Darlow BA,
Kusuda S, San Feliciano L, Yang J, Håkansson S, Mori R, Bassler D, Figueras-Aloy
J, Lee SK; International Network for Evaluating Outcomes (iNeo) of Neonates.
Neonatal Outcomes of Very Low Birth Weight and Very Preterm Neonates: An
International Comparison. J Pediatr. 2016 Oct;177:144-152.e6. doi:
10.1016/j.jpeds.2016.04.083. Epub 2016 May 24. PubMed PMID: 27233521.

29: Lang T, Klasson S, Larsson E, Johansson ME, Hansson GC, Samuelsson T.
Searching the Evolutionary Origin of Epithelial Mucus Protein Components-Mucins
and FCGBP. Mol Biol Evol. 2016 Aug;33(8):1921-36. doi: 10.1093/molbev/msw066.
Epub 2016 Apr 4. PubMed PMID: 27189557; PubMed Central PMCID: PMC4948705.

30: Siaw JT, Wan H, Pfeifer K, Rivera VM, Guan J, Palmer RH, Hallberg B.
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and
growth in ALK-positive neuroblastoma cells, Drosophila and mice. Oncotarget. 2016
May 17;7(20):29011-22. doi: 10.18632/oncotarget.8508. PubMed PMID: 27049722;
PubMed Central PMCID: PMC5045374.

31: Dyberg C, Papachristou P, Haug BH, Lagercrantz H, Kogner P, Ringstedt T,
Wickström M, Johnsen JI. Planar cell polarity gene expression correlates with
tumor cell viability and prognostic outcome in neuroblastoma. BMC Cancer. 2016
Mar 31;16:259. doi: 10.1186/s12885-016-2293-2. PubMed PMID: 27036398; PubMed
Central PMCID: PMC4818482.

32: Yamazaki Y, Palmer L, Alexandre C, Kakugawa S, Beckett K, Gaugue I, Palmer
RH, Vincent JP. Godzilla-dependent transcytosis promotes Wingless signalling in
Drosophila wing imaginal discs. Nat Cell Biol. 2016 Apr;18(4):451-7. doi:
10.1038/ncb3325. Epub 2016 Mar 14. PubMed PMID: 26974662; PubMed Central PMCID:
PMC4817240.

33: Mao Y, Eissler N, Blanc KL, Johnsen JI, Kogner P, Kiessling R. Targeting
Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control
Spontaneous Neuroblastoma. Clin Cancer Res. 2016 Aug 1;22(15):3849-59. doi:
10.1158/1078-0432.CCR-15-1912. Epub 2016 Mar 8. PubMed PMID: 26957560.

34: Bogen D, Brunner C, Walder D, Ziegler A, Abbasi R, Ladenstein RL, Noguera R,
Martinsson T, Amann G, Schilling FH, Ussowicz M, Benesch M, Ambros PF, Ambros IM.
The genetic tumor background is an important determinant for heterogeneous
MYCN-amplified neuroblastoma. Int J Cancer. 2016 Jul 1;139(1):153-63. doi:
10.1002/ijc.30050. Epub 2016 Mar 22. PubMed PMID: 26910568; PubMed Central PMCID:
PMC4949549.

35: Li S, Fell SM, Surova O, Smedler E, Wallis K, Chen ZX, Hellman U, Johnsen JI,
Martinsson T, Kenchappa RS, Uhlén P, Kogner P, Schlisio S. The 1p36 Tumor
Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling
Mitochondrial Fission and Apoptosis. Dev Cell. 2016 Jan 25;36(2):164-78. doi:
10.1016/j.devcel.2015.12.029. PubMed PMID: 26812016.

36: Fransson S, Östensson M, Djos A, Javanmardi N, Kogner P, Martinsson T.
Estimation of copy number aberrations: Comparison of exome sequencing data with
SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in
neuroblastoma. Int J Oncol. 2016 Mar;48(3):1103-16. doi: 10.3892/ijo.2016.3349.
Epub 2016 Jan 19. PubMed PMID: 26794043.

37: Olsson M, Beck S, Kogner P, Martinsson T, Carén H. Genome-wide methylation
profiling identifies novel methylated genes in neuroblastoma tumors. Epigenetics.
2016;11(1):74-84. doi: 10.1080/15592294.2016.1138195. Epub 2016 Jan 19. PubMed
PMID: 26786290; PubMed Central PMCID: PMC4846113.

38: Wickström M, Dyberg C, Milosevic J, Einvik C, Calero R, Sveinbjörnsson B,
Sandén E, Darabi A, Siesjö P, Kool M, Kogner P, Baryawno N, Johnsen JI.
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of
Wnt signalling prevents chemoresistance. Nat Commun. 2015 Nov 25;6:8904. doi:
10.1038/ncomms9904. PubMed PMID: 26603103; PubMed Central PMCID: PMC4674781.

39: Biswas S, Wood M, Joshi A, Bown N, Strain L, Martinsson T, Campbell J,
Ashworth A, Swain A. Exome Sequencing of an Adult Pituitary Atypical Teratoid
Rhabdoid Tumor. Front Oncol. 2015 Oct 23;5:236. doi: 10.3389/fonc.2015.00236.
eCollection 2015. PubMed PMID: 26557502; PubMed Central PMCID: PMC4617150.

40: Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, Bäckhed
F, Nielsen J. The gut microbiota modulates host amino acid and glutathione
metabolism in mice. Mol Syst Biol. 2015 Oct 16;11(10):834. doi:
10.15252/msb.20156487. PubMed PMID: 26475342; PubMed Central PMCID: PMC4631205.

41: Guan J, Umapathy G, Yamazaki Y, Wolfstetter G, Mendoza P, Pfeifer K, Mohammed
A, Hugosson F, Zhang H, Hsu AW, Halenbeck R, Hallberg B, Palmer RH. FAM150A and
FAM150B are activating ligands for anaplastic lymphoma kinase. Elife. 2015 Sep
29;4:e09811. doi: 10.7554/eLife.09811. PubMed PMID: 26418745; PubMed Central
PMCID: PMC4658194.

42: Mondal T, Subhash S, Vaid R, Enroth S, Uday S, Reinius B, Mitra S, Mohammed
A, James AR, Hoberg E, Moustakas A, Gyllensten U, Jones SJ, Gustafsson CM, Sims
AH, Westerlund F, Gorab E, Kanduri C. MEG3 long noncoding RNA regulates the TGF-β
pathway genes through formation of RNA-DNA triplex structures. Nat Commun. 2015
Jul 24;6:7743. doi: 10.1038/ncomms8743. PubMed PMID: 26205790; PubMed Central
PMCID: PMC4525211.

43: Stewart JB, Alaei-Mahabadi B, Sabarinathan R, Samuelsson T, Gorodkin J,
Gustafsson CM, Larsson E. Simultaneous DNA and RNA Mapping of Somatic
Mitochondrial Mutations across Diverse Human Cancers. PLoS Genet. 2015 Jun
30;11(6):e1005333. doi: 10.1371/journal.pgen.1005333. eCollection 2015 Jun.
PubMed PMID: 26125550; PubMed Central PMCID: PMC4488357.

44: Berbegall AP, Villamón E, Piqueras M, Tadeo I, Djos A, Ambros PF, Martinsson
T, Ambros IM, Cañete A, Castel V, Navarro S, Noguera R. Comparative genetic study
of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive
genetic profile neuroblastic tumors. Oncogene. 2016 Mar 17;35(11):1423-32. doi:
10.1038/onc.2015.200. Epub 2015 Jun 29. PubMed PMID: 26119945.

45: Pandey GK, Kanduri C. Long noncoding RNAs and neuroblastoma. Oncotarget. 2015
Jul 30;6(21):18265-75. Review. PubMed PMID: 26087192; PubMed Central PMCID:
PMC4621889.

46: Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen JI,
Korotkova M, Kogner P, Jakobsson PJ. COX/mPGES-1/PGE2 pathway depicts an
inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A.
2015 Jun 30;112(26):8070-5. doi: 10.1073/pnas.1424355112. Epub 2015 Jun 15.
PubMed PMID: 26080408; PubMed Central PMCID: PMC4491767.

47: Kanduri C, Kantojärvi K, Salo PM, Vanhala R, Buck G, Blancher C, Lähdesmäki
H, Järvelä I. The landscape of copy number variations in Finnish families with
autism spectrum disorders. Autism Res. 2016 Jan;9(1):9-16. doi: 10.1002/aur.1502.
Epub 2015 Jun 6. PubMed PMID: 26052927.

48: Kanduri C. Long noncoding RNAs: Lessons from genomic imprinting. Biochim
Biophys Acta. 2016 Jan;1859(1):102-11. doi: 10.1016/j.bbagrm.2015.05.006. Epub
2015 May 22. Review. PubMed PMID: 26004516.

49: Witek B, El Wakil A, Nord C, Ahlgren U, Eriksson M, Vernersson-Lindahl E,
Helland Å, Alexeyev OA, Hallberg B, Palmer RH. Targeted Disruption of ALK Reveals
a Potential Role in Hypogonadotropic Hypogonadism. PLoS One. 2015 May
8;10(5):e0123542. doi: 10.1371/journal.pone.0123542. eCollection 2015. PubMed
PMID: 25955180; PubMed Central PMCID: PMC4425494.

50: Pandey GK, Kanduri C. Fighting Neuroblastomas with NBAT1. Oncoscience. 2015
Feb 18;2(2):79-80. eCollection 2015. PubMed PMID: 25859549; PubMed Central PMCID:
PMC4381699.

51: Sandén E, Dyberg C, Krona C, Visse E, Carén H, Northcott PA, Kool M, Ståhl N,
Persson A, Englund E, Johnsen JI, Siesjö P, Darabi A. Aberrant immunostaining
pattern of the CD24 glycoprotein in clinical samples and experimental models of
pediatric medulloblastomas. J Neurooncol. 2015 May;123(1):1-13. doi:
10.1007/s11060-015-1758-5. Epub 2015 Mar 29. PubMed PMID: 25820321.

52: Duggimpudi S, Larsson E, Nabhani S, Borkhardt A, Hoell JI. The cell cycle
regulator CCDC6 is a key target of RNA-binding protein EWS. PLoS One. 2015 Mar
9;10(3):e0119066. doi: 10.1371/journal.pone.0119066. eCollection 2015. PubMed
PMID: 25751255; PubMed Central PMCID: PMC4353705.

53: Kopparapu PK, Miranda C, Fogelstrand L, Mishra K, Andersson PO, Kanduri C,
Kanduri M. MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic
lymphocytic leukemia. FEBS J. 2015 May;282(10):1939-52. doi: 10.1111/febs.13245.
Epub 2015 Mar 9. PubMed PMID: 25703238.

54: Söderberg-Nauclér C, Johnsen JI. Cytomegalovirus in human brain tumors: Role
in pathogenesis and potential treatment options. World J Exp Med. 2015 Feb
20;5(1):1-10. doi: 10.5493/wjem.v5.i1.1. eCollection 2015 Feb 20. Review. PubMed
PMID: 25699229; PubMed Central PMCID: PMC4308527.

55: Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard
J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa
A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T,
Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A,
Villamon E, Tonini GP. Influence of segmental chromosome abnormalities on
survival in children over the age of 12 months with unresectable localised
peripheral neuroblastic tumours without MYCN amplification. Br J Cancer. 2015 Jan
20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4. PubMed PMID:
25356804; PubMed Central PMCID: PMC4453444.

56: Bandaru S, Grönros J, Redfors B, Çil Ç, Pazooki D, Salimi R, Larsson E, Zhou
AX, Ömerovic E, Akyürek LM. Deficiency of filamin A in endothelial cells impairs
left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2015
Feb 1;105(2):151-9. doi: 10.1093/cvr/cvu226. Epub 2014 Oct 24. PubMed PMID:
25344364.

57: Fransson S, Hansson M, Ruuth K, Djos A, Berbegall A, Javanmardi N,
Abrahamsson J, Palmer RH, Noguera R, Hallberg B, Kogner P, Martinsson T.
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a
novel mechanism of ALK activation in neuroblastoma tumors. Genes Chromosomes
Cancer. 2015 Feb;54(2):99-109. doi: 10.1002/gcc.22223. Epub 2014 Sep 23. PubMed
PMID: 25251827.

58: Tang KW, Hellstrand K, Larsson E. Absence of cytomegalovirus in high-coverage
DNA sequencing of human glioblastoma multiforme. Int J Cancer. 2015 Feb
15;136(4):977-81. doi: 10.1002/ijc.29042. Epub 2014 Jul 7. PubMed PMID: 24961996.